Skip to content

Clinical trials

Phase 1 Muscular Atrophy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy Phase: Phase 1 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20101
20111
20121
20171
20181
20192
20202
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Withdrawn2
Terminated1
Not yet recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
University of Utah3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Baylor College of Medicine1
High Point Pharmaceuticals, LLC.1
Hospital for Special Surgery, New York1
McMaster University1
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China1
Pfizer1
Shan May Yong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy16
Anorexia2
Asthenia2
Cachexia2
Carcinoma, Non-Small-Cell Lung2
COVID-191
Colorectal Neoplasms1
Fatigue1
Hypokinesia1
Insulin Resistance1

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.